WST — West Pharmaceutical Services Inc · P/E 35, rev $1.72B

West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.

Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.

Use this WST page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the WST quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the WST SEC filings page. Lician reads the product cache first so this HTML stays unique to West Pharmaceutical Services Inc even when a live quote feed is slow.

West Pharmaceutical Services Inc latest statements (FY2025)

Latest cached year on this hub. Full WST income, balance, and cash tables.

  • Revenue$3.07B
  • Net Income$493.7M
  • Total Assets$4.27B
  • Total Debt$0
  • Free Cash Flow$468.9M

WST recent filings